Organisation: Sandoz

Brussels courts ban rebranding of generic parallel imports

These decisions are the first by national courts to interpret the CJEU’s preliminary ruling in Joined Cases C‑253/20 and C‑254/20.

13 June 2024

Landmark CJEU ruling clarifies limits of rebranding generics as branded medicines

The court provided much needed guidance on how to reconcile trademark rights and the free movement of goods in relation to the parallel import of generic medicines.

02 December 2022

Managing global portfolios: practical tips from brand legal experts at Novartis

Featured in Special Report 2021 Q2: Inside in-house operations - how to build world-class trademark functions and portfolios

Successful brand building leads to portfolios that require careful management. Novartis’ Svetlana Korzhin and David Lossignol share what has worked for them.

07 July 2021

High Court dismisses Glaxo's passing-off claim for competitor's use of the colour purple

The decision of the High Court of England & Wales in Glaxo Wellcome UK Ltd v Sandoz Ltd reaffirms the well-established principles of the tort of passing off and the difficulties of proving goodwill in a colour.

06 November 2019

Colour marks: still a grey area?

Colour marks remain difficult to obtain, but brand owners can take certain steps to enhance their chances of success.

01 October 2019

Daniel Wellington keeps a minimalistic portfolio to focus on a bulletproof enforcement strategy

With its origins in Instagram, Swedish watch company Daniel Wellington is no stranger to online counterfeit issues. The IP team’s core activity lies in enforcement, working both offline and online to purge fake goods.

05 July 2019

Zoetis trademark team triumphs in a year of major acquisitions

Zoetis’ Jane Ungaro shares her trademark strategy and methodology after a record-breaking year for acquisitions to reveal how Zoetis pipped Pfizer and Specsavers to WTR's Healthcare and Life Sciences Team of the Year.

04 July 2019

How Novartis is building a consistent brand strategy across four business units

In an exclusive interview, Myrtha Hurtado Rivas from pharmaceutical giant Novartis reveals how changes to the company’s trademark strategy created more effective cross-unit cooperation.

31 January 2019

A-Z guide of EU trademark court practice and performance: Spain to UK

In the final part of our series, trademark counsel from law firms across Europe provide an overview of the performance of their countries’ EU trademark courts over the last two years.

17 August 2018

“We try to take smart risks”: Sandoz International’s business-focused reproach to rights management

How Sandoz International, this year’s <em>WTR</em> Industry Awards Healthcare and Life Sciences Team of the Year, adapts its enforcement strategies to keep one step ahead of infringers.

19 June 2018